
Recro Appoints Laura L. Parks, Ph.D. to Board of Directors
EXTON, PA — Recro Pharma, Inc. (NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug …
Recro Appoints Laura L. Parks, Ph.D. to Board of Directors Read More